When Saurabh Arora talks about Lybrate’s achievements, his demeanour is calm and content. His tone oscillates between assured and enthusiastic as he narrates the story of Lybrate—how he brought the most funded startup in the telemedicine space to life. As soon as the subject of competition arises, Arora suddenly shifts to an alert, almost feline defence mode. He has marked his territory. If someone wants to enter it, he needs to know who that is.

Lybrate’s closest competitor Doctor Insta has raised one-fourth of its funding and built a business model inclined towards serving businesses, not users directly. It’s nowhere near becoming a threat to Lybrate. “Real competition,” Arora, founder of Lybrate, believes, “is the guy in the next room, who has the next big idea. Who is thinking out of the box, solving problems we have not yet been able to.”

Arora does not know, yet. It is not the ‘next big idea’ that he will soon compete with. His competition will be the sheer number of users backed by infinite resources. Will Lybrate be able to prepare for what is to come? In short, Jio.

Earlier this year, Reliance quietly launched the JioHealthHub app, exclusively for Jio subscribers. Arora shows the app on his phone. It is just a health data storage app, in beta version. He knows that, but what he doesn’t know is that soon it will bring the doctor to the phone screen. The JioHealthHub app, according to Google Play, has been downloaded between 100,000 and 500,000 times so far. A tenth of Lybrates’ reach at best. But Jio considers each of the 100 million users as potential customers. And converting them to app users is just a matter of time, is Reliance Jio’s motto. Once out of beta testing, the company plans pre-installing the app for every Jio subscriber. And once it gets doctors on the app, JioHealthHub will become ready to compete with Lybrate.

An image of JioHealthHub's introductory page (Screenshots are disabled on the app)

Meanwhile, with $11.4 million from Tiger Global, Nexus Venture Partners and Ratan Tata, Lybrate has proved that there’s a compelling need for teleconsultations between patients and doctors. Since its launch in January 2015, the app has convinced 100,000 doctors to provide e-consultations. It claims that it has 4.5 million downloads and serves as a platform for 6 million interactions a month by way of searches for doctors, health queries and patient-doctor communication. (The Ken could not independently verify these numbers.)

Earning doctors

Since its launch in January 2015, the Lybrate app has convinced 100,000 doctors to provide e-consultations. It claims that it has 4.5 million downloads and serves as a platform for 6 million interactions a month by way of searches for doctors, health queries and patient-doctor communication

Neither is focused on profits or more users, just yet.

AUTHOR

Ruhi Kandhari

Ruhi writes on the impact of healthcare policies, trends in the healthcare sector and developments on the implementation of Electronic Health Records in India. She has an M. Sc. in Development Studies from the London School of Economics.

View Full Profile

Subscribe to read this story

The Ken is the only business subscription you need. Questions?

 

Premium

  • 5 original and reported longform business stories every week
  • Access to ONLY India edition
  • Close to 250 exclusive stories every year
  • Full access to over 5 years of paywalled stories
  • Pick up to 5 premium subscriber newsletters
  • 4 original and reported longform business stories each week
  • Access to ONLY Southeast Asia edition
  • Close to 200 exclusive stories every year
  • Full access to all paywalled stories since March 2020
  • Pick up to 5 premium subscriber newsletters

Rs. 2,750 /year

$ 120 /year

India Edition
Subscribe Subscribe
Most Asked For

Borderless

  • 8 original and reported longform business stories each week
  • Access to both India and Southeast Asia editions
  • Close to 400 exclusive stories every year
  • Full access to over 5 years of paywalled stories across India and Southeast Asia
  • Unlimited access to all premium subscriber newsletters
  • Visual Stories

Rs. 4,200 /year

Subscribe
 

Echelon

  • 8 original and reported longform business stories each week
  • Access to both India and Southeast Asia editions
  • Close to 400 exclusive stories every year
  • Full access to over 5 years of paywalled stories across India and Southeast Asia
  • Unlimited access to all premium subscriber newsletters
  • Visual Stories
  • Bonus annual gift subscription
  • Priority access to all new products and features

Rs. 8,474 /year

Subscribe
Or

Questions?

What kind of subscription plans do you offer?

We have three types of subscriptions
- Premium which gives you access to either the India or the Southeast Asia edition.
- Borderless which gives you complete access to The Ken across both editions
- Echelon which gives you complete access to The Ken across both editions along with a bonus gift subscription

What do I get if I subscribe?

The Premium edition gives you access to stories in that edition along with any five subscriber-only newsletters of your choice.

The Borderless and Echelon subscription gives you complete access to The Ken across editions and unlimited access to as many newsletters as you like.

What topics do you usually write about?

We publish sharp, original and reported stories on technology, business and healthcare. Our stories are forward-looking, analytical and directional — supported by data, visualisations and infographics. We use language and narrative that is accessible to even lay readers. And we optimise for quality over quantity, every single time.

Our specialised subscriber-only newsletters are written by our expert, award-winning journalists and cover a range of topics across finance, retail, clean energy, cryptocurrency, ed-tech and many more.

How many newsletters do you have?

We are constantly adding specialised subscriber-only newsletters all the time. All of these are written by our team of award-winning journalists on a specialised topic.

You can see the list of newsletters that we publish over here.

Does a Premium subscription to your Indian edition get me access to the Southeast Asia edition? Or vice-versa?

Afraid not. Each edition is separate with its own subscription plan. The India edition publishes stories focused on India. The Southeast Asia edition is focused on Southeast Asia. We may occasionally cross-publish stories from one edition to the other.

We recommend the Borderless or the Echelon Plan which will give you access to stories across both editions.

Do you have a mobile app?

Yes! We have a top-rated mobile app on both iOS and Android which allows you to read on-the-go and has some amazing features like the ability to bookmark stories, save on your device, dark mode, and much more. It’s really the best way to read The Ken.

Is there a free trial?

You can sign up for a free account to experience The Ken and understand our products better. We’ll send you some free stories and newsletters occasionally, and you can access our archive of previously published free stories. You can stay on the free account as long as you’d like.

The vast majority of our stories, articles and newsletters can be accessed only by a paid subscription.

Do you offer any discounts?

Sorry, no. Our journalism is funded completely by our subscribers. We believe that quality journalism comes at a price, and readers trust and pay us so that we can remain independent.

Do you offer refunds?

No. We allow you to sample our journalism for free before signing up, and after you do, we stand by its quality. But we do not offer refunds.

I am facing some trouble purchasing a subscription. What can I do?

Just write to us at support@the-ken.com with details. We’ll help you out.

I have a few more questions. How can I reach out to you?

Sure. Just email us at info@the-ken.com or follow us on Twitter.